I have follicular lymphoma, a form of blood cancer that is considered very treatable ... In large part, these are the same ...

—Most follicular lymphoma cases exhibit classic clinicopathologic and molecular features, but a range of less common histopathologic variants have been documented, confounding diagnosis and ...

Follicular lymphoma is a very diverse disease, and decisions to treat in the frontline are made based on histology, disease burden and patient symptoms. The general approach should be a ...

Patients with follicular lymphoma can often be monitored clinically ... indicated when the patient develops constitutional symptoms, progressive lymphadenopathy, splenomegaly, effusions, organ ...

The most common type is diffuse large B-cell lymphoma. Other aggressive types include mantle cell, lymphoblastic, Burkitt, ...

It attaches to CD20 proteins on lymphoma cells and to CD3 proteins ... Your health care provider will watch you for CRS symptoms, such as severe headache, fever, and increased heart rate.

Christopher R. Flowers, MD, MS, discusses what the current treatment landscape of follicular lymphoma looks like.

Follicular lymphoma usually appears as painless, slowly growing lymph nodes. In the early stages of disease there are typically no symptoms, but at advanced stages the patient may experience ...

Leukemia red spots are an early warning sign of leukemia. Symptoms of non-Hodgkin's lymphoma may include painless swelling of one or more lymph nodes, night sweats, itching, and more. Doctors ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

The remaining patients had the following: marginal zone lymphoma (10.9%); follicular lymphoma (2.5%); Burkitt lymphoma (2.2%) ...